Robert A. Ashley is listed as an executive officer on 5 SEC Form D filings by 1 issuer between Mar 2013 and Mar 2014: IMMUNIC, INC. (New York, United States (as filed: X1) — biotechnology — 2013–2014; $200M reported sold to 62 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Aron Stern (5 shared filings), Duane Nash (5 shared filings), Errol R. Halperin (5 shared filings), J. Michael Millis (5 shared filings), Phillip Croxford (5 shared filings) and 13 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Robert A. Ashley and found 5 differences: Offering amount changed between filings; Same name, different state: "Robert Ashley" (VA) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.